道明光學(002632.SZ):目前產品在美國市場所涉業務佔比極小
格隆匯6月18日丨道明光學(002632.SZ)於投資者互動平台表示,公司近年來積極佈局海外市場,專門搭建銷售網絡,以提升公司車牌級反光膜在國外的市佔率和銷售業績,目前產品主要出口歐洲、東南亞、南美等地區。公司目前產品在美國市場所涉業務佔比極小,主要生產原材料也不涉及美國進口,故關税壁壘對公司無重大影響。同時,部分海外國家仍採用3M美國本土生產產品,如海外其他國家採取關税反制,將有利於國內反光材料公司的海外市場銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.